AI assistant
Sending…
Vir Biotechnology, Inc. — Director's Dealing 2020
May 26, 2020
32538_dirs_2020-05-26_f44091a4-954d-4127-a6fa-69b7c58b5f78.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2020-05-21
Reporting Person: Nishar Dipchand (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-05-21 | Stock Option (Right to Buy) | $37.06 | A | 28888 | Acquired | 2030-05-21 | Common Stock (28888) | Direct |
More from Vir Biotechnology, Inc.
Regulatory Filings
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 16
Board/Management Information
2026
Apr 10
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Regulatory Filings
2026
Mar 23
Board/Management Information
2026
Mar 4
Director's Dealing
2026
Mar 3
Capital/Financing Update
2026
Mar 2
Capital/Financing Update
2026
Feb 26